MoonLake Immunotherapeutics Class A Company Profile
NASDAQ: MLTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 11:13 AM ET
MoonLake Immunotherapeutics at a glance
MoonLake Immunotherapeutics Class A (NASDAQ: MLTX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Zug. MoonLake Immunotherapeutics is led by Dr. Jorge Santos da Silva Ph.D. and employs about 130 people. The company's shares have traded publicly since 2020.
At a market capitalization of $931.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001821586, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does MoonLake Immunotherapeutics do?
MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Business description based on the company's public filings.
Company information
- Legal name
- MoonLake Immunotherapeutics Class A
- Ticker
- NASDAQ: MLTX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Jorge Santos da Silva Ph.D.
- Employees
- 130
- Headquarters
- Dorfstrasse 29, Zug, United States
- Phone
- 41 415108022
- Website
- moonlaketx.com
- IPO year
- 2020
- Market cap
- $931.92M
- SEC CIK
- 0001821586
Companies similar to MoonLake Immunotherapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ANLAdlai Nortye Group Ltd. ADR | 14.54 | +3.45% | $936.02M | vs MLTX |
| AKTSAktis Oncology Inc. | 16.99 | -5.61% | $944.98M | vs MLTX |
| ANROAlto Neuroscience Inc. | 23.26 | -1.11% | $912.77M | vs MLTX |
| KURAKura Oncology Inc. | 10.25 | -3.94% | $911.85M | vs MLTX |
| SVRASavara Inc. | 4.68 | -4.20% | $960.53M | vs MLTX |
| SPTXSeaport Therapeutics Inc. | 18.12 | +1.06% | $969.97M | vs MLTX |
| LTGOLatigo Biotherapeutics Inc. | 14.81 | -4.61% | $981.56M | vs MLTX |
| RIGLRigel Pharmaceuticals Inc. | 46.75 | -2.58% | $873.28M | vs MLTX |